Screener
Aurinia Pharmaceuticals AUPH Net product sales — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Net product sales | $79,412 | $66,574 | $152,975 | $126,545 |
| License, collaboration and royalty revenue | 3,808 | 3,434 | 7,950 | 5,928 |
| Total revenue | 83,220 | 70,008 | 160,925 | 132,473 |
| Operating expenses | ||||
| Cost of revenue | 6,555 | 7,115 | 13,060 | 15,689 |
| Selling, general and administrative | 23,508 | 26,018 | 45,537 | 46,357 |
| Research and development | 13,050 | 7,432 | 20,520 | 13,175 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's net product sales — revenue?
- Aurinia Pharmaceuticals (AUPH) reported net product sales — revenue of $79.41M in Q2 2026.
- How has Aurinia Pharmaceuticals's net product sales — revenue changed year-over-year?
- Aurinia Pharmaceuticals's net product sales — revenue increased by 19.3% year-over-year, from $66.57M to $79.41M.
- What is the long-term trend for Aurinia Pharmaceuticals's net product sales — revenue?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's net product sales — revenue has grown at a 56.3% compound annual growth rate (CAGR), from $45.49M to $271.35M.
- What does net product sales — revenue mean?
- This metric represents the total revenue generated from the direct sale of pharmaceutical products to customers, net of allowances, rebates, and discounts. It serves as a primary indicator of market adoption and commercial success for the company's therapeutic portfolio. Tracking this figure helps investors evaluate the growth trajectory and commercial scalability of the firm's core product offerings.
Ask your AI about Aurinia Pharmaceuticals's net product sales — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude